Status:
RECRUITING
Stress, Inflammation and Neuroimaging in Major Depressive Disorder as Compared to Premenstrual Dysphoric Disorder
Lead Sponsor:
University Hospital Tuebingen
Conditions:
MDD
PMDD
Eligibility:
FEMALE
18-40 years
Brief Summary
Premenstrual dysphoric disorder (PMDD) is a sex-specific depressive disorder where depressive symptom severity drastically changes in relation to menstrual cycle phase. It is characterized by late lut...
Detailed Description
In the proposed study the investigators aim to investigate in more detail how women with MDD and women with PMDD differ in their stress response from healthy women. The investigators are directly comp...
Eligibility Criteria
Inclusion
- Women,
- age between 18 and 40 years (no menopausal women),
- regular menstrual cycles (25-31 days),
- normal body mass index (18-35 kg/m2),
- German language fluency
Exclusion
- any neurological or mental disease (only for healthy participants)
- hormonal, metabolic or chronical diseases
- pregnancy
- women who gave birth or were breastfeeding within the last year
- women with any kind of steroid hormonal treatment
- oral contraceptive treatment in the last three months
- psychotropic treatment, only if regular
- engagement in competitive sports
- shift work
Key Trial Info
Start Date :
January 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06130371
Start Date
January 4 2024
End Date
July 1 2025
Last Update
February 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen, Klinik für Psychiatrie und Psychotherapie
Tübingen, Baden-Wurttemberg, Germany, 72076